These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11347482)

  • 1. [Immunopathology of systemic lupus erythematosus].
    Bach JF
    Rev Med Interne; 2000 Dec; 21 Suppl 4():456s. PubMed ID: 11347482
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives.
    Steup-Beekman G; Steens S; van Buchem M; Huizinga T
    Lupus; 2007; 16(5):329-34. PubMed ID: 17576734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
    Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
    Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus.
    Vasquez R; Tseng LC; Victor S; Zhang S; Chong BF
    Arch Dermatol; 2012 May; 148(5):651-5. PubMed ID: 22782164
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Engelbertsen D; Wigren M; Gustafsson JT; Gunnarsson I; Elvin K; Jensen-Urstad K; Fredrikson GN; Nilsson J
    Clin Exp Immunol; 2015 Sep; 181(3):417-26. PubMed ID: 25959453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus.
    Daha MR
    Lupus; 2008 May; 17(5):385-8. PubMed ID: 18490413
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinical significance of autoantibodies to plasminogen activator inhibitor 1 in systemic lupus erythematosus.
    Bates RL; Payne SJ; Drury SL; Nelson PN; Isenberg DA; Murphy JJ; Frampton G
    Lupus; 2003; 12(8):617-22. PubMed ID: 12945721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lepromatous leprosy complicated with systemic lupus erythematosus.
    Ohkawa S; Ozaki M; Izumi S
    Dermatologica; 1985; 170(2):80-3. PubMed ID: 3979635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to detect antibodies to the second extracellular loop of the serotonin 5-HT4 receptor in systemic lupus erythematosus and primary Sjögren's syndrome.
    Cavill D; Waterman S; Gordon TP
    Lupus; 2002; 11(3):197-8. PubMed ID: 11999887
    [No Abstract]   [Full Text] [Related]  

  • 13. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
    Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
    Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of systemic lupus erythematosus].
    Hamashima Y
    Arerugi; 1986 Jun; 35(6):379-86. PubMed ID: 3533012
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic Lupus Erythematosus: Correlation Between Immunodysregulation and Clinical Manifestations.
    Carneiro OI; Brito IH
    Curr Rheumatol Rev; 2016; 12(2):154-61. PubMed ID: 26496783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
    Aldar H; Lapa AT; Bellini B; Sinicato NA; Postal M; Fernandes PT; Costallat LT; Marini R; Appenzeller S
    Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.